Semmax Financial Advisors’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $684 | Sell |
8
-274
| -97% | -$23.4K | ﹤0.01% | 376 |
|
|
2025
Q1 | $2.03K | Sell |
282
-77
| -21% | -$555 | ﹤0.01% | 326 |
|
|
2024
Q4 | $5.43K | Buy |
359
+65
| +22% | +$984 | ﹤0.01% | 254 |
|
|
2024
Q3 | $10.9K | Hold |
294
| – | – | ﹤0.01% | 213 |
|
|
2024
Q2 | $11.2K | Hold |
294
| – | – | ﹤0.01% | 230 |
|
|
2024
Q1 | $12.3K | Hold |
294
| – | – | ﹤0.01% | 201 |
|
|
2023
Q4 | $16.5K | Hold |
294
| – | – | 0.01% | 194 |
|
|
2023
Q3 | $20.6K | Buy |
+294
| New | +$20.6K | 0.01% | 164 |
|
|
2022
Q4 | $24K | Hold |
294
| – | – | 0.01% | 145 |
|
|
2022
Q3 | $17K | Hold |
294
| – | – | 0.01% | 149 |
|
|
2022
Q2 | $28K | Buy |
294
+231
| +367% | +$22K | 0.01% | 131 |
|
|
2022
Q1 | $4K | Hold |
63
| – | – | ﹤0.01% | 218 |
|
|
2021
Q4 | $5K | Hold |
63
| – | – | ﹤0.01% | 205 |
|
|
2021
Q3 | $6K | Buy |
+63
| New | +$6K | ﹤0.01% | 189 |
|